Therapeutic Hepatitis B Adenovirus Injection (T101)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Therapeutic Hepatitis B Adenovirus Injection (T101), covering 2021-02-08 to 2021-02-08. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients [Phase 2]